NCT03179904 2026-02-24TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast CancerMayo ClinicPhase 2 Active not recruiting17 enrolled 10 charts
NCT05743621 2025-11-21Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate CancerWeill Medical College of Cornell UniversityPhase 1 Recruiting30 enrolled